Identification of a variant form of PZR lacking immunoreceptor tyrosine-based inhibitory motifs

Biochemical and Biophysical Research Communications

Volumn 303, Issue 4, 2003, Pages 1028-1033

  Zhao, Runxiang ^a   Zhao, Zhizhuang Joe ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Chromosomal localization; Motif; SHP 2; Splicing; Tyrosine phosphorylation

Indexed keywords

CONCANAVALIN A; IMMUNOGLOBULIN; IMMUNOGLOBULIN PZR; ISOPROTEIN; PHOSPHATASE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 1Q; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA SPLICING;

EID: 0037453249     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00484-4     Document Type: Article

References (34)

1. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell. 80:1995;225-236.
2. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
3. Pawson T. Protein modules and signalling networks. Nature. 373:1995;573-580.
4. Long E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:1999;875-904.
5. Muta T., Kurosaki T., Misulovin Z., Sanchez M., Nussenzweig M.C., Ravetch J.V. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature. 369:1994;70-73.
6. Colonna M., Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:1995;405-408.
7. Meyaard L., Adema G.J., Chang C., Woollatt E., Sutherland G.R., Lanier L.L., Phillips J.H. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity. 7:1997;283-290.
8. Stamenkovic I., Seed B. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature. 345:1990;74-77.
9. Blery M., Kubagawa H., Chen C.C., Vely F., Cooper M.D., Vivier E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA. 95:1998;2446-2451.
10. Newman P.J., Berndt M.C., Gorski J., White G.C., Lyman S., Paddock C., Muller W.A. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 247:1990;1219-1222.
11. Kharitonenkov A., Chen Z., Sures I., Wang H., Schilling J., Ullrich A. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature. 386:1997;181-186.
12. Fujioka Y., Matozaki T., Noguchi T., Iwamatsu A., Yamao T., Takahashi N., Tsuda M., Takada T., Kasuga M. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol. Cell. Biol. 16:1996;6887-6899.
13. Zhao Z.J., Zhao R. Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2. J. Biol. Chem. 273:1998;29367-29372.
14. Mousseau D.D., Banville D., L'Abbé D., Bouchard P., Shen S.-H. PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRβ J. Biol. Chem. 275:2000;4467-4474.
15. Freeman S.D., Kelm S., Barber E.K., Crocker P.R. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood. 85:1995;2005-2012.
16. Cornish A.L., Freeman S., Forbes G., Ni J., Zhang M., Cepeda M., Gentz R., Augustus M., Carter K.C., Crocker P.R. Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood. 92:1998;2123-2132.
17. Patel N., Brinkman-Van der Linden E.C., Altmann S.W., Gish K., Balasubramanian S., Timans J.C., Peterson D., Bell M.P., Bazan J.F., Varki A., Kastelein R.A., Patel N., Linden E.C., Altmann S.W., Gish K., Balasubramanian S., Timans J.C., Peterson D., Bell M.P., Bazan J.F., Varki A., Kastelein R.A. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily. J. Biol. Chem. 274:1999;22729-22738.
18. Nicoll G., Ni J., Li D., Klenerman P., Munday J., Dubock S., Mattei M.-G., Crocker P.R. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J. Biol. Chem. 274:1999;34089-34095.
19. Falco M., Biassoni R., Bottino C., Vitale M., Sivori S., Augugliaro R., Moretta L., Moretta A. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 190:1999;793-802.
20. Karlhofer F.M., Ribaudo R.K., Yokoyama W.M. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature. 358:1992;66-70.
21. Le Dréan E., Vély F., Olcese L., Cambiaggi A., Guia S., Krystal G., Gervois N., Moretta A., Jotereau F., Vivier E. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 28:1998;264-276.
22. Adachi T., Flaswinkel H., Yakura H., Reth M., Tsubata T. Cutting edge: the B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J. Immunol. 160:1998;4662-4665.
23. + immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity Eur. J. Immunol. 26:1996;1266-1272.
24. Zhao R., Zhao Z.J. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs. J. Biol. Chem. 275:2000;5453-5459.
25. Feng G.S. Shp-2 tyrosine phosphatase: signaling one cell or many. Exp. Cell Res. 253:1999;47-54.
26. Zhao R., Guerrah A., Tang H., Zhao Z.J. Cell surface glycoprotein PZR is a major mediator of concanavalin A-induced cell signaling. J. Biol. Chem. 277:2002;7882-7888.
27. Zhao Z., Tan Z., Diltz C.D., You M., Fischer E.H. Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J. Biol. Chem. 271:1996;22251-22255.
28. Hayasaka K., Himoro M., Wang Y., Takata M., Minoshima S., Shimizu N., Miura M., Uyemura K., Takada G., Protein Nucleotide Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ). Genomics. 17:1993;755-758.
29. Harding A.E. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain. 118:1995;809-818.
30. Smith J.R., Freije D., Carpten J.D., Gronberg H., Xu J., Isaacs S.D., Brownstein M.J., Bova G.S., Guo H., Bujnovszky P., Nusskern D.R., Damber J.E., Bergh A., Emanuelsson M., Kallioniemi O.P., Walker-Daniels J., Bailey-Wilson J.E., Beaty T.H., Meyers D.A., Walsh P.C., Collins F.S., Trent J.M., Isaacs W.B. Major susceptibility locus for prostate cancer on chromosome1 suggested by a genome-wide search. Science. 274:1996;1371-1374.
31. Shapiro L., Doyle J.P., Hensley P., Colman D.R., Hendrickson W.A. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron. 17:1996;435-449.
32. Choe S. Packing of myelin protein zero. Neuron. 17:1996;363-365.
33. Yarden Y., Ullrich A. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57:1988;443-478.
34. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., Conte R., Poggi A., Moretta A., Moretta L. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183:1996;645-650.